[
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=1f96b4661eed878fcf2a490d5efd758ae151aa9950a2662acf14bcfcb92ed9b1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742401860,
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "id": 133264730,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=1f96b4661eed878fcf2a490d5efd758ae151aa9950a2662acf14bcfcb92ed9b1"
    }
  },
  {
    "ts": null,
    "headline": "Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.",
    "summary": "Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot medicines.",
    "url": "https://finnhub.io/api/news?id=767ca2e82b7b17116a057c58df3f68f3c096219ffbd4033a0168b9634305f251",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742399640,
      "headline": "Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.",
      "id": 133324412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot medicines.",
      "url": "https://finnhub.io/api/news?id=767ca2e82b7b17116a057c58df3f68f3c096219ffbd4033a0168b9634305f251"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity",
    "summary": "Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The market had another outstanding year in 2024, with the S&P 500 rising 25.0%. The strategy had an even better year, with net returns of 28.4%. Looking a bit […]",
    "url": "https://finnhub.io/api/news?id=64e5196b09722b623c1b31d1381b10a208de3d78c7c4de3bc62993164e7b544a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742392046,
      "headline": "Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity",
      "id": 133268499,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The market had another outstanding year in 2024, with the S&P 500 rising 25.0%. The strategy had an even better year, with net returns of 28.4%. Looking a bit […]",
      "url": "https://finnhub.io/api/news?id=64e5196b09722b623c1b31d1381b10a208de3d78c7c4de3bc62993164e7b544a"
    }
  },
  {
    "ts": null,
    "headline": "The Lag 7",
    "summary": "While a decline of 8% sounds relatively modest, individual stocks in the index, especially the ten largest, have seen much larger declines. Click to read.",
    "url": "https://finnhub.io/api/news?id=a21efd2cc65d72528575d5ae12850dcda1afe0e148f7aeff6a08ab32efe16668",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742391660,
      "headline": "The Lag 7",
      "id": 133256640,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2021524839/image_2021524839.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "While a decline of 8% sounds relatively modest, individual stocks in the index, especially the ten largest, have seen much larger declines. Click to read.",
      "url": "https://finnhub.io/api/news?id=a21efd2cc65d72528575d5ae12850dcda1afe0e148f7aeff6a08ab32efe16668"
    }
  },
  {
    "ts": null,
    "headline": "3 Market-Beating Stocks to Target This Week",
    "summary": "Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.",
    "url": "https://finnhub.io/api/news?id=05248b4fe53e74799ed3f5497596ca9b5710419b408b07e9439a22be050d628c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742389265,
      "headline": "3 Market-Beating Stocks to Target This Week",
      "id": 133324414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.",
      "url": "https://finnhub.io/api/news?id=05248b4fe53e74799ed3f5497596ca9b5710419b408b07e9439a22be050d628c"
    }
  },
  {
    "ts": null,
    "headline": "Ampersand Biomedicines Raises Series B Financing",
    "summary": "Ampersand Biomedicines: * AMPERSAND BIOMEDICINES RAISES SERIES B FINANCING * AMPERSAND BIOMEDICINES - SERIES B FUNDING FROM INVESTORSINCLUDING AMPERSAND'S FOUNDER,...",
    "url": "https://finnhub.io/api/news?id=afc324c431c1a736e1939bfe5a207ff93056e4a07fd7cc21f263344bed98d412",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742368000,
      "headline": "Ampersand Biomedicines Raises Series B Financing",
      "id": 133239210,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Ampersand Biomedicines: * AMPERSAND BIOMEDICINES RAISES SERIES B FINANCING * AMPERSAND BIOMEDICINES - SERIES B FUNDING FROM INVESTORSINCLUDING AMPERSAND'S FOUNDER,...",
      "url": "https://finnhub.io/api/news?id=afc324c431c1a736e1939bfe5a207ff93056e4a07fd7cc21f263344bed98d412"
    }
  }
]